Metabolite profiling of small cerebrospinal fluid sample volumes with gas chromatography–mass spectrometry: application to a rat model of multiple sclerosis
暂无分享,去创建一个
T. Hankemeier | S. Bijlsma | T. Luider | B. Muilwijk | L. Coulier | I. Bobeldijk | M. Noga | M. Tienstra | A. Attali | H. V. Aken | E. Suidgeest | T. Tuinstra
[1] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.
[2] S. Wold,et al. Partial least squares analysis with cross‐validation for the two‐class problem: A Monte Carlo study , 1987 .
[3] R. Fishman. Cerebrospinal Fluid in Diseases of the Nervous System , 1992 .
[4] S. Harik. Cerebrospinal Fluid in Diseases of the Nervous System, 2nd Ed. , 1994, Neurology.
[5] L. Laffel. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes , 1999, Diabetes/metabolism research and reviews.
[6] I. Jolliffe. Principal Component Analysis , 2002 .
[7] N. Reo. NMR-BASED METABOLOMICS , 2002, Drug and chemical toxicology.
[8] M. Harrington,et al. Human Cerebrospinal Fluid , 2004 .
[9] L. Liotta,et al. CSF proteome: a protein repository for potential biomarker identification , 2005, Expert review of proteomics.
[10] A. Smilde,et al. Assessing the statistical validity of proteomics based biomarkers. , 2007, Analytica chimica acta.
[11] J. van der Greef,et al. The art and practice of systems biology in medicine: mapping patterns of relationships. , 2007, Journal of proteome research.
[12] D. Wishart,et al. The human cerebrospinal fluid metabolome. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] W. R. Wikoff,et al. Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. , 2008, The Journal of clinical investigation.
[14] P. Andersen,et al. Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[15] W. R. Wikoff,et al. Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data. , 2009, Analytical chemistry.
[16] E. Nevedomskaya,et al. Gas chromatography/atmospheric pressure chemical ionization-time of flight mass spectrometry: analytical validation and applicability to metabolic profiling. , 2009, Analytical chemistry.
[17] Frans M van der Kloet,et al. Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. , 2009, Journal of proteome research.
[18] Y. Oda,et al. Quantitative profiling of polar cationic metabolites in human cerebrospinal fluid by reversed-phase nanoliquid chromatography/mass spectrometry. , 2009, Analytical chemistry.
[19] T. Northen,et al. Mass spectrometry based metabolomics and enzymatic assays for functional genomics. , 2009, Current opinion in microbiology.
[20] John C. S. Lui,et al. Profiling and identification of P2P traffic , 2009, Comput. Networks.
[21] S. Wijmenga,et al. Quantitative Proteomics and Metabolomics Analysis of Normal Human Cerebrospinal Fluid Samples* , 2010, Molecular & Cellular Proteomics.
[22] T. Hankemeier,et al. Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives , 2010, Metabolomics.
[23] T. Hankemeier,et al. Metabolic profiling of ultrasmall sample volumes with GC/MS: from microliter to nanoliter samples. , 2010, Analytical chemistry.
[24] M. Viant,et al. NMR‐based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases – a diagnostic tool? , 2009, NMR in biomedicine.
[25] R. Béné,et al. Nano-HPLC–MS analysis of phospholipids in cerebrospinal fluid of Alzheimer’s disease patients—a pilot study , 2010, Analytical and bioanalytical chemistry.
[26] John M. Walker,et al. Metabolic Profiling , 2011, Methods in Molecular Biology.
[27] P. Andersen,et al. Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS , 2011, PloS one.
[28] S. Wijmenga,et al. NMR and pattern recognition can distinguish neuroinflammation and peripheral inflammation. , 2011, Journal of proteome research.
[29] T. Hankemeier,et al. Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis , 2011, Metabolomics.
[30] F. Suits,et al. Profiling and identification of cerebrospinal fluid proteins in a rat EAE model of multiple sclerosis. , 2012, Journal of proteome research.
[31] L. Cantley,et al. Metabolomics of Human Cerebrospinal Fluid Identifies Signatures of Malignant Glioma* , 2012, Molecular & Cellular Proteomics.